Molly Carey

Currently launching two products with different mechanisms of action for Myasthenia Gravis in the neuromuscular space. Rystiggo (FcRn inhibitor via subcutaneous infusion) and Zilbrysq (self administered C5 inhibitor)

• Advocate for Rare Disease patients and maintain a strong collaboration with matrix partners
• 400% growth over 2 quarters
• Detail contest winner
• First Zilbrysq prescription in region
• Built strong relationships in just 6 months of launch

• 200% volume growth in an under-performing territory, within 2 quarters of hire date (2022)
• Lead and collaborated with teammates, both regionally and nationally, to promote biologic Arcalyst (rilonacept)
• Executed marketing programs and conferences across customer segments using approved resources
• Call points included Cardiology and Rheumatology
• Formed collaborative partnerships with decision-makers at HCOs
• Possessed an in-depth expertise of recurrent pericarditis and Arcalyst
• Collaborated effectively and compliantly with MSL
• Regional Advisory Board committee member
• Worked closely with MA, PAL, and staff for prescription pull-through
• Q4 Kicker award for new writers.

• Regional Sales Trainer (Southeast 2022)
• Ranked #1 in region for Xyosted volume (Q1,2,3,4 2021)
• Ranked #1 in region for Nocdurna, #7 in nation (Q3 2021)
• Ranked # 1 in region for Xyosted and Otrexup volume (2020)
• Ranked #3 in region for Xyosted volume (2019)
• Ranked #5 in nation for Xyosted growth (Q2 2020)
• Ranked #2 in nation for Otrexup goal attainment (Q3 2020)
• Ranked #1 in region for Xyosted attainment (Q1 and Q2 2020)
• Regional MVP Award (2021).

• Ranked #4 in region; Top 15% of company (Q1, Q2 2018)
• Promoted Type II Diabetes portfolio including Farxiga and Bydureon
• Implemented a strategic and aggressive marketing strategy to increase market share for product portfolio
• Created Publicis/AZ Boca District Liaison leadership role to assist new representatives
• SPOT Leadership award.

• Generated $2.2 million in revenue from 2011-2017
• Voted Best Boutique by the New Times (2016)
• WPLG Channel 10 Top 3 Winner for Best Clothing Store (2013, 2014).

• Ranked #1 in district for Uloric Goal Attainment (Q4 2009)
• Ranked #1 in district for Uloric TRx's and Share Change (Q2 2009)
• Ranked #8 in region for Portfolio Goal Attainment (Q3 2009)
• Regional Advisory Board Member (2009)
• POA Uloric lead presenter
• Created and implemented sales strategies within the district to help move market share
• Aggressively promoted new product launch of Uloric for gouty arthritis.

• Ranked #1 in district and #6 in region for entire portfolio attainment (July 2008)
• Ranked #3 in district and #15 in region for entire portfolio attainment (June 2008)
• Ranked #4 in region and top 7% of company for Clarinex portfolio attainment (July 2008)
• Ranked #5 in region and top 6% of company for Nasonex portfolio attainment (June 2008)
• Targeted Nephrology, Pulmonology, Pediatrics, Cardiology, Allergists, ENT, Dermatology, Primary Care.

• Built client base from 0 running accounts to over 20 running accounts, through aggressive cold calling within 6 months
• Increased gross profit by 35% in 2005 and 65% in 2006
• Personally produced over $200,000 gross profit for the company.

• Consulted with clients to create effective fund-raising campaigns
• Produced over $40,000 net profit for schools in Orange County, CA
• Developed public speaking skills through motivational presentations to large groups.

• Named top first-year dealer from our organization (based on gross profit), ranked #29 out of 1000 in the company (2000)
• Named top experienced dealer/manager, ranked #95 out of thousands (2001)
• Increased gross sales by 35% from previous year (2001)
• Received the President's Club Award for over $2300 net profit in one week for two consecutive weeks (2000, 2001)
• Awarded the Gold Award for working 75+ hours per week (2000, 2001).